Yoshioki Yamasaki

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Replacement Therapy

Idiopathic Pulmonary Fibrosis

Prognostic Factors

Systemic Sclerosis

Top Venues

International journal of rheumatic diseases

Expert review of clinical immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Yukiko Takakuwa, Yoshioki Yamasaki, Hiromi Matsushita, Tomofumi Kiyokawa, Machiko Mizushima, Kumiko Tonooka, Hiroko Nagafuchi, Shin Matsuoka, Seido Ooka, Kimito Kawahata
Long-term survival, causes of death, and prognostic factors for mortality in patients with microscopic polyangiitis and those with anti-neutrophil cytoplasmic antibody-positive interstitial lung disease: A single-center retrospective study. International journal of rheumatic diseases 26 (3) (2022)
Yukiko Takakuwa, Yoshioki Yamasaki, Hiromi Matsushita, Tomofumi Kiyokawa, Machiko Mizushima, Kumiko Tonooka, Hiroko Nagafuchi, Shin Matsuoka, Seido Ooka, Kimito Kawahata
Long-term survival, causes of death, and prognostic factors for mortality in patients with microscopic polyangiitis and those with anti-neutrophil cytoplasmic antibody-positive interstitial lung disease: A single-center retrospective study. International journal of rheumatic diseases 26 (3) (2022)
Yukiko Takakuwa, Yoshioki Yamasaki, Hiromi Matsushita, Tomofumi Kiyokawa, Machiko Mizushima, Kumiko Tonooka, Hiroko Nagafuchi, Shin Matsuoka, Seido Ooka, Kimito Kawahata
Long-term survival, causes of death, and prognostic factors for mortality in patients with microscopic polyangiitis and those with anti-neutrophil cytoplasmic antibody-positive interstitial lung disease: A single-center retrospective study. International journal of rheumatic diseases (2022)
Yoshioki Yamasaki, Masataka Kuwana
Nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease. Expert review of clinical immunology 16 (6) (2020)